CD63 and breast carcinoma: This is consistent with previous studies reporting an increase in CD63‐pHlourin events upon histamine stimulation of HeLa and HUVEC cells (Verweij et al., 2018), and ionomycin stimulation of the breast cancer cell line MDA‐MB‐231 (Messenger et al., 2018).